Microfluidic-Driven Assembly of RNA Nanocomplexes: Design, Process Control and Translational Perspectives in Oncology
Pharmaceutics · 29.05.2026 · 18 (6) · 679
DOI: 10.3390/pharmaceutics18060679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.05.2026. Verfasst von Ronan Pinto Nobrega Dos Santos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nanotechnology Engineering Department (PENt), Alberto Luiz Coimbra Institute for Graduate Studies and Research in Engineering (COPPE), Federal Univer…. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, Presidency for Turks Abroad and Related Communities, Scientific and Technological Research Council of Türkiye.
Abstract (Originalsprache)
RNA-based therapeutics are becoming increasingly important in oncology, particularly following the rapid development of mRNA technologies during the COVID-19 pandemic, but their success strongly depends on how efficiently they can be delivered to target cells. Microfluidic technologies have redefined the design and manufacturing of RNA-based nanocomplexes, as they enable precise control over physicochemical features that are critical for clinical translation in oncology. This review examines recent developments in microfluidic-assisted synthesis of RNA nanocarriers, with a focus on cancer applications. Through a detailed analysis of material systems, device architectures, and formulation strategies, we explore how laminar flow environments enable reproducible encapsulation, tunable particle size, and improved payload stability. We examine the microfluidic assembly of lipid nanoparticles and polymeric carriers for RNA delivery, highlighting strategies to enhance durability, bioavailability, and cellular uptake. Advancements in process optimization, including flow parameter refinement and inline monitoring, are discussed alongside the influence of device geometries on mixing dynamics and nucleation. Beyond formulation, we explore the integration of microfluidics with tumor-on-chip platforms to evaluate transport, penetration, and therapeutic response in physiologically relevant cancer models. By connecting technological innovation with preclinical application, this work outlines the trajectory toward next-generation, personalized RNA nanomedicines enabled by microfluidic precision.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanotechnology Engineering Department (PENt), Alberto Luiz Coimbra Institute for Graduate Studies and Research in Engineering (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-594, Brazil.
- Biomedical Engineering Department, Ankara University, 06830 Ankara, Türkiye.
- Turkish Energy, Nuclear and Mineral Research Agency, Boron Research Institute, 06530 Ankara, Türkiye.
- Chemical Engineering Department (PEQ), Alberto Luiz Coimbra Institute for Graduate Studies and Research in Engineering (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-594, Brazil.
- Integrated Technologies Application and Research Center, Ankara University, 06790 Ankara, Türkiye.
ORCID-Profile: Ronan Pinto Nobrega Dos Santos, Dana Celeste Betancourt Roldan, Muslum Guven, Lucas Campana Leite, Francisco Jacomine Madrid Furlan, Gabriel Rocha Mariano da Silva, Josie Pereira da Silva, José Carlos Pinto, Tiago Albertini Balbino
Förderung
- Scientific and Technological Research Council of Turkey
- Presidency for Turks Abroad and Related Communities
- Scientific and Technological Research Council of Türkiye
Zitieren
APA
Dos Santos, R. P. N., Betancourt Roldan, D. C., Guven, M., Leite, L. C., Furlan, F. J. M., da Silva, G. R. M., de Oliveira, V. A. P., Capriglione, C. D. S., da Silva, J. P., Pinto, J. C., Eş, I., & Balbino, T. A. (2026). Microfluidic-Driven Assembly of RNA Nanocomplexes: Design, Process Control and Translational Perspectives in Oncology. Pharmaceutics, 18(6), 679. https://doi.org/10.3390/pharmaceutics18060679
Vancouver
Dos Santos RPN, Betancourt Roldan DC, Guven M, Leite LC, Furlan FJM, da Silva GRM, et al. Microfluidic-Driven Assembly of RNA Nanocomplexes: Design, Process Control and Translational Perspectives in Oncology. Pharmaceutics. 2026;18(6):679. doi:10.3390/pharmaceutics18060679
BibTeX
@article{DosSantos2026,
author = {Dos Santos, Ronan Pinto Nobrega and Betancourt Roldan, Dana Celeste and Guven, Muslum and Leite, Lucas Campana and Furlan, Francisco Jacomine Madrid and da Silva, Gabriel Rocha Mariano and de Oliveira, Vitória Almeida Pessoa and Capriglione, Carolline da Silva and da Silva, Josie Pereira and Pinto, José Carlos and Eş, Ismail and Balbino, Tiago Albertini},
title = {Microfluidic-Driven Assembly of RNA Nanocomplexes: Design, Process Control and Translational Perspectives in Oncology},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {6},
pages = {679},
doi = {10.3390/pharmaceutics18060679}
}
EUVIMED